Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2022
FDA approves Cochlear implants for unilateral hearing loss
The U.S. Food and Drug Administration approved Cochlear Nucleus Implants for treatment of unilateral hearing loss and single-sided deafness.
2020
Nyxoah announces €25 million private financing round
Nyxoah announced a €25 million private financing round, with ResMed joining as a new shareholder. Completion was subject to customary closing conditions and expected later that month.